Johnson & Johnson Innovative Medicine

Johnson & Johnson Innovative Medicine
The Janssen Pharmaceutical Companies of Johnson & Johnson is now J&J Innovative Medicine.

Titusville Campus
1125 Trenton-Harbourton Road
Titusville, NJ 08560

Raritan Campus
1000 U.S. Route 202 South
Raritan, NJ 08869

Horsham Campus
800 Ridgeview Drive
Horsham, PA 19044
Phone: 1-800-JANSSENWebsite: https://www.janssen.com/us/Careers: www.janssen.com/us/careers

Latest news

FDA Approves Imaavy (nipocalimab-aahu) for the Treatment of Generalized Myasthenia Gravis (gMG)
30 April 2025
FDA Approves Tremfya (guselkumab) for Adult Patients with Moderately to Severely Active Crohn’s Disease
20 March 2025
Nipocalimab, the First and Only Investigational Treatment to be Granted U.S. FDA Breakthrough Therapy Designation for the Treatment of Adults with Moderate-to-Severe Sjögren’s Disease, has now Received Fast Track Designation
18 March 2025
Findings From Pivotal Nipocalimab Phase 3 Study in a Broad Antibody Positive Population of People Living with Generalized Myasthenia Gravis (gMG) Published in The Lancet Neurology
23 January 2025
Spravato (esketamine) Approved in the U.S. as the First and Only Monotherapy for Adults with Treatment-Resistant Depression
21 January 2025
Nipocalimab Granted U.S. FDA Priority Review for the Treatment of Generalized Myasthenia Gravis
9 January 2025
Nipocalimab is the First and Only Investigational Therapy Granted U.S. FDA Breakthrough Therapy Designation for the Treatment of Adults Living with Moderate-to-Severe Sjögren’s Disease
11 November 2024
Nipocalimab Demonstrates Sustained Disease Control in Adolescents Living with Generalized Myasthenia Gravis in Phase 2/3 study
15 October 2024
Rybrevant (amivantamab-vmjw) Plus Standard of Care Approved in the U.S. as First and Only Targeted Regimen to Cut Risk of Disease Progression by More Than Half in Second-Line EGFR-Mutated Advanced Lung Cancer
19 September 2024
Tremfya (guselkumab) Receives U.S. FDA Approval for Adults with Moderately to Severely Active Ulcerative Colitis
13 September 2024

Drugs Associated with Johnson & Johnson Innovative Medicine

Johnson & Johnson Innovative Medicine manufactures, markets and/or distributes more than 51 drugs in the United States. Medications listed here may also be marketed under different names in different countries. Non-US country and region specific information is not available on this page.

Brand/Generic Name	Reviews	Rating
Akeega Generic name: abiraterone/niraparib Drug class: antineoplastic combinations
Balversa Generic name: erdafitinib Drug class: multikinase inhibitors	1 review	10 / 10
Carvykti Generic name: ciltacabtagene autoleucel Drug class: miscellaneous antineoplastics
Concerta Generic name: methylphenidate Drug class: CNS stimulants	404 reviews	6.9 / 10
Darzalex Generic name: daratumumab Drug class: CD38 monoclonal antibodies	5 reviews	7.8 / 10
Darzalex Faspro Generic name: daratumumab/hyaluronidase Drug class: CD38 monoclonal antibodies	3 reviews	8.3 / 10
Ditropan XL Generic name: oxybutynin Drug class: urinary antispasmodics	5 reviews	9.4 / 10
Edurant Generic name: rilpivirine Drug class: NNRTIs
Elmiron Generic name: pentosan polysulfate sodium Drug class: miscellaneous genitourinary tract agents	94 reviews	7.4 / 10
Erleada Generic name: apalutamide Drug class: antiandrogens, hormones/antineoplastics	18 reviews	7.4 / 10
Haldol Generic name: haloperidol Drug class: miscellaneous antipsychotic agents	66 reviews	4.7 / 10
Haldol Decanoate Generic name: haloperidol Drug class: miscellaneous antipsychotic agents	3 reviews	3.3 / 10
Imbruvica Generic name: ibrutinib Drug class: BTK inhibitors	60 reviews	6.5 / 10
Intelence Generic name: etravirine Drug class: NNRTIs	2 reviews	8.0 / 10
Invega Generic name: paliperidone Drug class: atypical antipsychotics	211 reviews	4.8 / 10
Invega Hafyera Generic name: paliperidone Drug class: atypical antipsychotics	1 review	10 / 10
Invega Sustenna Generic name: paliperidone Drug class: atypical antipsychotics	180 reviews	3.8 / 10
Invega Trinza Generic name: paliperidone Drug class: atypical antipsychotics	33 reviews	6.5 / 10
Invokamet Generic name: canagliflozin/metformin Drug class: antidiabetic combinations	2 reviews	2.5 / 10
Invokamet XR Generic name: canagliflozin/metformin Drug class: antidiabetic combinations
Invokana Generic name: canagliflozin Drug class: SGLT-2 inhibitors	231 reviews	5.8 / 10
Lazcluze Generic name: lazertinib Drug class: EGFR inhibitors
Opsumit Generic name: macitentan Drug class: agents for pulmonary hypertension	10 reviews	8.2 / 10
Opsynvi Generic name: macitentan/tadalafil Drug class: agents for pulmonary hypertension
Ponvory Generic name: ponesimod Drug class: selective immunosuppressants
Prezcobix Generic name: cobicistat/darunavir Drug class: antiviral combinations	3 reviews	4.0 / 10
Prezista Generic name: darunavir Drug class: protease inhibitors	3 reviews	7.7 / 10
Procrit Generic name: epoetin alfa Drug class: recombinant human erythropoietins	5 reviews	3.8 / 10
Remicade Generic name: infliximab Drug class: antirheumatics, TNF alfa inhibitors	202 reviews	7.1 / 10
Risperdal Generic name: risperidone Drug class: atypical antipsychotics	229 reviews	6.0 / 10
Risperdal Consta Generic name: risperidone Drug class: atypical antipsychotics	14 reviews	6.0 / 10
Rybrevant Generic name: amivantamab Drug class: miscellaneous bispecific antibodies	4 reviews	8.5 / 10
Simponi Generic name: golimumab Drug class: TNF alfa inhibitors	116 reviews	6.3 / 10
Simponi Aria Generic name: golimumab Drug class: TNF alfa inhibitors	27 reviews	5.6 / 10
Sirturo Generic name: bedaquiline Drug class: diarylquinolines
Sporanox Generic name: itraconazole Drug class: azole antifungals	17 reviews	8.4 / 10
Spravato Generic name: esketamine Drug class: miscellaneous antidepressants	113 reviews	6.3 / 10
Stelara Generic name: ustekinumab Drug class: interleukin inhibitors	229 reviews	7.7 / 10
Symtuza Generic name: cobicistat/darunavir/emtricitabine/tenofovir alafenamide Drug class: antiviral combinations	8 reviews	8.2 / 10
Talvey Generic name: talquetamab Drug class: bispecific T-cell engagers (BiTE)	1 review	7.0 / 10
Tecvayli Generic name: teclistamab Drug class: bispecific T-cell engagers (BiTE)	5 reviews	9.4 / 10
Topamax Generic name: topiramate Drug class: carbonic anhydrase inhibitor anticonvulsants	597 reviews	6.1 / 10
Tracleer Generic name: bosentan Drug class: agents for pulmonary hypertension	4 reviews	9.5 / 10
Tremfya Generic name: guselkumab Drug class: interleukin inhibitors	88 reviews	7.2 / 10
Uptravi Generic name: selexipag Drug class: agents for pulmonary hypertension	22 reviews	5.5 / 10
Veletri Generic name: epoprostenol Drug class: agents for pulmonary hypertension	2 reviews	7.5 / 10
Ventavis Generic name: iloprost Drug class: agents for pulmonary hypertension
Vermox Generic name: mebendazole Drug class: anthelmintics	1 review	8.0 / 10
Xarelto Generic name: rivaroxaban Drug class: factor Xa inhibitors	197 reviews	5.5 / 10
Yondelis Generic name: trabectedin Drug class: alkylating agents
Zavesca Generic name: miglustat Drug class: miscellaneous metabolic agents
For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective).